Acta Med. 1998, 41: 23-26
Red Cell Distribution Width (RDW) as a Marker of Disease Activity in Patients with Hairy Cell Leukemia
Individual author index pages
Other articles of these authors
-
FIFTEEN YEARS OF SINGLE CENTER EXPERIENCE WITH STEM CELL TRANSPLANTATION FOR MULTIPLE MYELOMA: A RETROSPECTIVE ANALYSIS
Jakub Radocha, Vladimír Maisnar, Alžběta Zavřelová, Melanie Cermanová, Miriam Lánská, Miloslav Kmoníček, Ladislav Jebavý, Milan Bláha, Jaroslav Malý, Pavel Žák
2013, Vol. 56, Issue 1, pp. 9-13 -
CASE 2–2012: a 57-Year-Old Woman with Post-Transplant Lymphoproliferative Disorder after Allogeneic Stem Cell Transplantation for Primary Myelofibrosis
Milan Košťál, Pavel Žák, Eva Vejražková, Melánie Cermanová, Petra Bělohlávková, Alžběta Zavřelová, Filip Vrbacký, Tomáš Rozkoš, Markéta Nová
2012, Vol. 55, Issue 3, pp. 142-145 -
CASE 3-2011: Invasive Mucormycosis (Zygomycosis) after Bone Marrow Transplantation in a 26-Year-Old Man with Relapsing Acute Myeloid Leukaemia
Alžběta Zavřelová, Adéla Matějková, Markéta Nová, Petr Hoffmann, Vladimír Buchta, Pavel Žák
2011, Vol. 54, Issue 4, pp. 163-166 -
Improvement of Anaemia in Patients with Primary Myelofibrosis by Low-Dose Thalidomide and Prednisone
Petra Bělohlávková, Vladimír Maisnar, Jaroslava Voglová, Tomáš Buchler, Pavel Žák
2016, Vol. 59, Issue 2, pp. 50-53 -
Case 1-2009: A 65-Year-Old Woman with Three Months’ History of Progressive Dyspnea and Recurrent Episodes of Collapse
Pavel Žák, Helena Hornychová, Alena Štrasová, Jaroslava Bednářová
2009, Vol. 52, Issue 4, pp. 159-162 -
Addition of Rituximab Significantly Improves Outcomes in Patients with Diffuse Large B-cell Lymphoma – a Single-center, Retrospective Study
David Belada, Lukáš Smolej, Monika Hrudková, Pavla Štěpánková, Alice Sýkorová, Pavel Žák, Jiří Bukač, Jaroslav Malý
2007, Vol. 50, Issue 2, pp. 113-118 -
Treatment of Multifocal Multisystem BRAF Positive Langerhans Cell Histiocytosis with Cladribine, Surgery and Allogenic Stem Cell Transplantation
Filip Gabalec, Martin Šimkovič, Alžběta Zavřelová, Petra Kašparová, Paula Morávková, Marcela Kopáčová, Václav Masopust, Pavel Žák, Jan Čáp, Jakub Radocha
2017, Vol. 60, Issue 4, pp. 152-156 -
Successful Treatment of Iron Overload with Phlebotomies in Two Siblings with Congenital Dyserythropoietic Anemia – Type II (CDA-II)
Ladislav Chrobák
2006, Vol. 49, Issue 3, pp. 193-195 -
Excess of Pappenheimer Bodies (Siderocytes) in Two Splenectomized Siblings with Congenital Dyserythropoietic Anemia – Type II (CDA-II) and Iron Overload
Ladislav Chrobák, Jindřiška Matysová
2004, Vol. 47, Issue 3, pp. 187-188 -
Imatinib Mesylate (STI 571) – A New Oral Target Therapy For Chronic Myelogenous Leukemia (CML)
Ladislav Chrobák, Jaroslava Voglová
2003, Vol. 46, Issue 3, pp. 85-89 -
Intravascular Large B-Cell Lymphoma Presenting As Cutaneous Panniculitis
Karel Dědič, David Belada, Pavel Žák, Zdeněk Nožička
2003, Vol. 46, Issue 3, pp. 121-123 -
Paroxysmal Nocturnal Hemoglobinuria (Membrane Defect, Pathogenesis, Aplastic Anemia, Diagnosis)
Ladislav Chrobák
2000, Vol. 43, Issue 1, pp. 3-8 -
Minimal Residual Disease, Its Detection and Significance in Hairy-Cell Leukemia
Pavel Žák, Ladislav Chrobák, Karel Dědič
1999, Vol. 42, Issue 3, pp. 85-88 -
Is Factor V Leiden a Risk Factor for Fetal Loss?
Petr Dulíček, Ladislav Chrobák, Ivo Kalousek, Lenka Pešavová, Miroslav Pecka, Pravoslav Stránský
1999, Vol. 42, Issue 3, pp. 93-96 -
History of Hematology at the Charles University, Faculty of Medicine and Faculty Hospital in Hradec Králové
Ladislav Chrobák, Milan Bláha
1998, Vol. 41, Issue 3, pp. 145-153 -
Long-Term Results in Hairy Cell Leukemia Treated with 2-Chlorodeoxyadenosine
Ladislav Chrobák, Pavel Žák, Karel Podzimek, Lenka Plíšková, Jaroslava Foglová, Vladimír Maisnar, Petr Dulíček, Karel Dědič
1997, Vol. 40, Issue 2, pp. 41-45 -
Hirata’s Disease: Rare Cause of Hypoglycaemia in Caucasian Male
Kateřina Žibřidová, Barbora Havlínová, Eliška Svobodová, Pavel Žák, Jan Čáp, Filip Gabalec
2021, Vol. 64, Issue 1, pp. 50-54
